Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons

The progressive increase in the resistance rates to first- and second-line antibiotics has forced the reuse of colistin as last-line treatment for Acinetobacter baumannii infections, but the emergence of colistin-resistant strains is not uncommon. This has been long linked to acquired chromosomal mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zafer, Mai M., Hussein, Amira F. A., Al-Agamy, Mohamed H., Radwan, Hesham H., Hamed, Samira M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436201/
https://www.ncbi.nlm.nih.gov/pubmed/37600939
http://dx.doi.org/10.3389/fcimb.2023.1229473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436201/
https://www.ncbi.nlm.nih.gov/pubmed/37600939
http://dx.doi.org/10.3389/fcimb.2023.1229473

Ejemplares similares